editorial | Q871232 |
scholarly article | Q13442814 |
P2093 | author name string | Igor J Koralnik | |
P2860 | cites work | Progressive multifocal leukoencephalopathy: why gray and white matter | Q34307762 |
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy | Q34324861 | ||
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. | Q34803324 | ||
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals | Q35194420 | ||
JC virus antibody status underestimates infection rates | Q37079703 | ||
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab | Q39012188 | ||
Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays | Q41727049 | ||
An assay to quantify species-specific anti-JC virus antibody levels in MS patients | Q45352744 | ||
Anti-JC virus antibodies: implications for PML risk stratification | Q45373492 | ||
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. | Q47763052 | ||
Cellular and humoral immune response in progressive multifocal leukoencephalopathy | Q73892409 | ||
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays | Q33186315 | ||
A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient | Q33956020 | ||
Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus | Q33964857 | ||
Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy | Q34213119 | ||
Risk of natalizumab-associated progressive multifocal leukoencephalopathy | Q34275329 | ||
P433 | issue | 6 | |
P304 | page(s) | 789-791 | |
P577 | publication date | 2014-11-17 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | Finger pointing to JC virus: a tale of two indexes | |
P478 | volume | 76 |
Q54230581 | JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus. |
Q48246057 | JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab. |
Q28083338 | Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate |